Sectra AB (publ) SECT-B.ST
Nasdaq Stockholm · Healthcare · Medical Devices
327.60 SEK
−1.0%
2026-11-06
Keep this stock on your watchlist and set email alerts for prices, reports and important announcements where available.
Annual accounts for Sectra
| SEK million | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | 2,351 | 2,966 | 3,243 | 3,547 |
| EBITDA | 573 | 654 | 842 | 852 |
| Net income | 375 | 428 | 563 | 564 |
| Balance sheet | ||||
| Equity | 1,297 | 1,570 | 1,917 | 2,136 |
| Total debt | 82 | 32 | 87 | 76 |
| Cash | 825 | 805 | 1,342 | 1,810 |
| Net debt | −743 | −773 | −1,254 | −1,734 |
| Ratios and per share | ||||
| EBITDA margin | 24.4% | 22.1% | 26.0% | 24.0% |
| Profit margin | 16.0% | 14.4% | 17.4% | 15.9% |
| Return on equity | 28.9% | 27.3% | 29.4% | 26.4% |
| Earnings/share (SEK) | 1.95 | 2.22 | 2.92 | 2.93 |
| Book value/share (SEK) | 6.73 | 8.15 | 9.95 | 11.08 |
| Shares outstanding (M) | 193 | 193 | 193 | 193 |
From the annual statements (Yahoo Finance), in the currency the company reports in. Per-share figures use the shares at the year end. Charts and annual figures →
Key figures
| P/E | 112.0 |
| P/B | 29.6 |
| EV / EBITDA | 72.0 |
| Net debt / EBITDA | −2.0 |
| Return on equity | 26.4% |
| Profit margin | 15.9% |
| Beta 1Y | 0.69 |
| Revenue growth 1Y | +9.4% |
| Revenue CAGR 3Y | +14.7% |
| Earnings/share CAGR 3Y | +14.6% |
| ROE avg. 3Y | 27.7% |
Ratios use the latest annual report that was public 90 days after the year end.
Dividends per share (SEK)
| 2026 | 2.30 |
| 2025 | 2.10 |
| 2024 | 1.10 |
| 2023 | 1.10 |
| 2022 | 1.00 |
Not investment advice. Figures may contain errors from the data source.